Europe's Innovative Medicines Initiative has recruited 7 pharmas to each contribute up to 50,000 compounds from their proprietary libraries for a public-private partnership called the European Lead Factory. The pharmas will have access to an expanded chemical space, and academic members of the factory will be able to run experiments with high-quality molecules.